Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Pimentel

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
BMC Oral Health|May 15, 2026
Muscle weakness, greater fat mass, lower hematocrit levels, and advanced age in a diagnostic prediction model of periodontitis in adults with obesity: a cross-sectional studyKarina Sarno Paes Alves Dias, Virgílio Santana-Júnior, Luciana Mara Barbosa Pereira, et al.
Frontiers in Oral Health|March 6, 2026
Gingival bleeding and lower number of natural teeth are predictive factors of low muscle strength in obese adults: a cross-sectional studyKarina Sarno Paes Alves Dias, Virgílio Santana-Júnior, Luciana Mara Barbosa Pereira, et al.
RMD Open|March 8, 2020
Eligibility criteria for biologic disease-modifying antirheumatic drugs in axial spondyloarthritis: going beyond BASDAIJose Marona, Alexandre Sepriano, Santiago Rodrigues-Manica, et al.
Acta Reumatologica Portuguesa|July 12, 2012
Portuguese recommendations for the use of biological therapies in patients with axial spondyloarthritis--December 2011 updatePedro Machado, Alexandra Bernardo, Ana Rita Cravo, et al.
Medicine|December 22, 2016
Gender differences among patients with primary ankylosing spondylitis and spondylitis associated with psoriasis and inflammatory bowel disease in an iberoamerican spondyloarthritis cohortMargarita Landi, Hernán Maldonado-Ficco, Rodolfo Perez-Alamino, et al.
Acta Reumatologica Portuguesa|August 10, 2018
The GO-DACT protocol: a multicentre, randomized, double-blind, parallel-group study to compare the efficacy of golimumab in combination with methotrexate (MTX) versus MTX monotherapyElsa Vieira-Sousa, Helena Canhão, Pedro Alves, et al.
Joint Bone Spine|October 31, 2024
Late-onset axial spondyloarthritis: A multicentre nationwide studyMargarida Lucas Rocha, Sofia Ramiro, Rita Pinheiro Torres, et al.
Annals of the Rheumatic Diseases|April 9, 2021
EULAR Points to Consider (PtC) for designing, analysing and reporting of studies with work participation as an outcome domain in patients with inflammatory arthritisAnnelies Boonen, Polina Putrik, Mary Lucy Marques, et al.
Seminars in Arthritis and Rheumatism|July 25, 2025
The use of ASDAS to evaluate disease activity and response to treatment in patients with axial spondyloarthritis starting the first biological drug: Are ASAS recommendations being followed?Mariana Emília Santos, Sofia Ramiro, Désirée van der Heijde, et al.
Clinical and Experimental Rheumatology|July 14, 2025
Vision-related quality of life in spondyloarthritis patients with acute anterior uveitis on golimumab: the GO-VISION studyInês Leal, Ana Teresa Melo, Carolina Ochôa Matos, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
BMC Oral Health|May 15, 2026
Muscle weakness, greater fat mass, lower hematocrit levels, and advanced age in a diagnostic prediction model of periodontitis in adults with obesity: a cross-sectional studyKarina Sarno Paes Alves Dias, Virgílio Santana-Júnior, Luciana Mara Barbosa Pereira, et al.
Frontiers in Oral Health|March 6, 2026
Gingival bleeding and lower number of natural teeth are predictive factors of low muscle strength in obese adults: a cross-sectional studyKarina Sarno Paes Alves Dias, Virgílio Santana-Júnior, Luciana Mara Barbosa Pereira, et al.
RMD Open|March 8, 2020
Eligibility criteria for biologic disease-modifying antirheumatic drugs in axial spondyloarthritis: going beyond BASDAIJose Marona, Alexandre Sepriano, Santiago Rodrigues-Manica, et al.
Acta Reumatologica Portuguesa|July 12, 2012
Portuguese recommendations for the use of biological therapies in patients with axial spondyloarthritis--December 2011 updatePedro Machado, Alexandra Bernardo, Ana Rita Cravo, et al.
Medicine|December 22, 2016
Gender differences among patients with primary ankylosing spondylitis and spondylitis associated with psoriasis and inflammatory bowel disease in an iberoamerican spondyloarthritis cohortMargarita Landi, Hernán Maldonado-Ficco, Rodolfo Perez-Alamino, et al.
Acta Reumatologica Portuguesa|August 10, 2018
The GO-DACT protocol: a multicentre, randomized, double-blind, parallel-group study to compare the efficacy of golimumab in combination with methotrexate (MTX) versus MTX monotherapyElsa Vieira-Sousa, Helena Canhão, Pedro Alves, et al.
Joint Bone Spine|October 31, 2024
Late-onset axial spondyloarthritis: A multicentre nationwide studyMargarida Lucas Rocha, Sofia Ramiro, Rita Pinheiro Torres, et al.
Annals of the Rheumatic Diseases|April 9, 2021
EULAR Points to Consider (PtC) for designing, analysing and reporting of studies with work participation as an outcome domain in patients with inflammatory arthritisAnnelies Boonen, Polina Putrik, Mary Lucy Marques, et al.
Seminars in Arthritis and Rheumatism|July 25, 2025
The use of ASDAS to evaluate disease activity and response to treatment in patients with axial spondyloarthritis starting the first biological drug: Are ASAS recommendations being followed?Mariana Emília Santos, Sofia Ramiro, Désirée van der Heijde, et al.
Clinical and Experimental Rheumatology|July 14, 2025
Vision-related quality of life in spondyloarthritis patients with acute anterior uveitis on golimumab: the GO-VISION studyInês Leal, Ana Teresa Melo, Carolina Ochôa Matos, et al.
Pageof 10